This week, we delve into Bristol Myers Squibb's significant acquisition of Mirati Therapeutics. Also, we look at the U.S. Food and Drug Administration’s formation of a digital health advisory committee and the groundbreaking approval of a genetic test for cancer risk assessment. Additionally, we spotlight ... READ MORE >
5 things to know in life sciences: Week of Oct. 2, 2023
This week we explore a significant financing for an artificial intelligence-based biotech company, an investment in medtech by the UK government and a U.S. Food and Drug Administration visit to a major medtech incubator. We also look at a new product using AI to provide information regarding clinical ... READ MORE >
5 things to know in life sciences: Week of Sept. 25, 2023
This week we explore the development of a drug to grow teeth and the start of clinical trials for rabies vaccines. We also look at the labor shortage in biopharma manufacturing and Medicare’s solvency concerns. In addition, we highlight a survey which shows that artificial intelligence is the top area for ... READ MORE >
5 things to know in life sciences: Week of Sept. 18, 2023
This week we explore the Food and Drug Administration’s new guidance related to single trial approvals and the National Institutes of Health’s commencement of a trial for a universal flu vaccine. We also look at the start of clinical trials for CRISPR-based leukemia treatment and the FDA’s rejection of a ... READ MORE >
5 things to know in life sciences: Week of Sept. 11, 2023
This week we explore the approval of updated COVID-19 vaccines, the announcement of two biotech initial public offerings and a special purpose acquisition company transaction. We also look at the development of a new COVID-19 vaccine and decreased U.S. and European investment in Chinese biotech ... READ MORE >
5 things to know in life sciences: Week of Aug. 28, 2023
This week we explore Medicare’s price negotiations, gene therapies to target hearing restoration and an innovative approach to pharmacy benefits management, or PBM. In addition, we look at a medical device that can be used to detect atrial fibrillation and the acquisition of a contract development and ... READ MORE >
5 things to know in life sciences: Week of Aug. 21, 2023
This week we explore the impending patent cliff, rising layoffs in biopharma and the use of Artificial Intelligence (AI) for Alzheimer’s and dementia care. In addition, we look at salaries in the medical devices industry and approval of a new medical device for the treatment of overactive bladder. ... READ MORE >
5 things to know in life sciences: Week of Aug. 14, 2023
This week, we spotlight an increase in UK biotech funding, the approval of the first sterilization system for 3D-printed medical devices and the decline of radiation therapy in cancer treatment. We also delve into COVID-19 vaccine testing against new variants. Lastly, we examine the approval of a patient ... READ MORE >
5 things to know in life sciences: Week of Aug. 7, 2023
This week, we spotlight the use of an oral pill for postpartum depression, a change in Meta’s approach to artificial intelligence, and an expedited regulatory review process for medical devices. We also delve into major increases in research and development spending among large pharmaceutical companies. ... READ MORE >
5 things to know in life sciences: Week of July 31, 2023
This week we spotlight a groundbreaking wearable ultrasound scanner, the invention of a tiny tentacled robot for potential early lung cancer detection, as well as the appointment of a new director at the National Institute of Allergy and Infectious Diseases. Additionally, we look at the approval of a ... READ MORE >